Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | kinesin family member 11 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.1747 | 0.1747 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0245 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.007 | 0.1576 | 0.1576 |
Schistosoma mansoni | hypothetical protein | 0.0074 | 0.1747 | 0.2208 |
Brugia malayi | Pre-SET motif family protein | 0.0223 | 0.8236 | 0.8236 |
Loa Loa (eye worm) | hypothetical protein | 0.0109 | 0.3253 | 0.3253 |
Loa Loa (eye worm) | hypothetical protein | 0.0263 | 1 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0223 | 0.8236 | 0.8236 |
Echinococcus multilocularis | kinesin family 1 | 0.0247 | 0.9321 | 0.9321 |
Trichomonas vaginalis | set domain proteins, putative | 0.0253 | 0.9582 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.004 | 0.0245 | 0.0245 |
Brugia malayi | RNA binding protein | 0.007 | 0.1576 | 0.1576 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0263 | 1 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.004 | 0.0245 | 0.0309 |
Brugia malayi | RNA recognition motif domain containing protein | 0.007 | 0.1576 | 0.1576 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.004 | 0.0245 | 0.0245 |
Loa Loa (eye worm) | TAR-binding protein | 0.007 | 0.1576 | 0.1576 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.1576 | 0.1992 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0263 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.0245 | 0.0309 |
Schistosoma mansoni | survival motor neuron protein | 0.0054 | 0.0841 | 0.1063 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0109 | 0.3253 | 0.3253 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.1576 | 0.1992 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0245 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.007 | 0.1576 | 0.1576 |
Onchocerca volvulus | 0.0253 | 0.9582 | 1 | |
Brugia malayi | hypothetical protein | 0.004 | 0.0245 | 0.0245 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.007 | 0.1576 | 0.1576 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.1576 | 0.1992 |
Schistosoma mansoni | hypothetical protein | 0.0215 | 0.7914 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.1576 | 0.1992 |
Echinococcus multilocularis | tar DNA binding protein | 0.007 | 0.1576 | 0.1576 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0245 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0245 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.0841 | 0.1063 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0109 | 0.3253 | 0.3253 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.1576 | 0.1992 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0109 | 0.3253 | 0.3253 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0074 | 0.1747 | 0.1747 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0054 | 0.0841 | 0.0841 |
Echinococcus granulosus | kinesin family 1 | 0.0247 | 0.9321 | 0.9321 |
Brugia malayi | TAR-binding protein | 0.007 | 0.1576 | 0.1576 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Inhibition of ATPase activity of kid by luminescent kinase assay | ChEMBL. | 19167222 | |
IC50 (binding) | = 3.63 umol/L | Inhibition of microtubule-stimulated recombinant Eg5 assessed as inhibition ATP hydrolysis by luminescent kinase assay | ChEMBL. | 19167222 |
IC50 (functional) | = 33 umol/L | Cytotoxicity against human HeLa cells after 48 hrs by MTS assay | ChEMBL. | 19167222 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.